According to the needs of enterprise development, the company moved to Xining in early 2000, and successfully completed the shareholding system transformation of the enterprise, separating government from enterprises, with clear property rights, with a registered capital of more than 6 million yuan, and the enterprise was renamed as "Qinghai Gladanton Pharmaceutical Co., Ltd."

According to the development requirements of national pharmaceutical production enterprises and the overall planning of Qinghai Economic and Trade Commission, the company purchased 36 mu of land in Xining Biotechnology Industrial Park, Qinghai Province, and began to build GMP certification technical transformation project on June 65438+1 October1day, 2002, with a total investment of more than 20 million yuan. In June 2004, it successfully passed the national GMP certification. The enterprise owns more than 40 Chinese medicine products, including 24 Tibetan medicines and 6 national exclusive products/kloc-0, with an annual output value of 300 million yuan.